Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Carole Diane Mitnick, Sc.D.

TitleAssociate Professor of Global Health and Social Medicine
InstitutionHarvard Medical School
DepartmentGlobal Health and Social Medicine
AddressHarvard Medical School
Social Medicine
641 Huntington Ave
Boston MA 02115
Phone617/432-6018
Fax617/432-6045

 Mentoring 
 completed student projects
Detection of hypertension as risk factor in chronic kidney disease and access to medical care in Quezalguaque, Leon, Nicaragua
International, 06/16/10 - 08/08/10
Spanish and Service Learning Program in Santiago, Chile 2005
International, 06/19/05 - 08/12/05
Chile Spanish Language and Service Learning Program 2005
International, 06/20/05 - 08/12/05
An assessment of the efficacy, access-to-care, and sustainability of a recently established national cataract elimination program in Peru
International, 06/18/09 - 08/10/09
Service Learning Program in Santiago, Chile - summer 2005
Spanish, 06/19/05 - 08/12/05

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Parr JB, Mitnick CD, Atwood SS, Chalco K, Bayona J, Becerra MC. Concordance of resistance profiles in households of patients with multidrug-resistant tuberculosis. Clin Infect Dis. 2014 Feb; 58(3):392-5.
    View in: PubMed
  2. Brigden G, Nyang'wa BT, du Cros P, Varaine F, Hughes J, Rich M, Horsburgh CR, Mitnick CD, Nuermberger E, McIlleron H, Phillips PP, Balasegaram M. Principles for designing future regimens for multidrug-resistant tuberculosis. Bull World Health Organ. 2014 Jan 1; 92(1):68-74.
    View in: PubMed
  3. Anderson LF, Tamne S, Watson JP, Cohen T, Mitnick C, Brown T, Drobniewski F, Abubakar I. Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Euro Surveill. 2013; 18(40).
    View in: PubMed
  4. Seung KJ, Becerra MC, Atwood SS, Alcántara F, Bonilla CA, Mitnick CD. Salvage therapy for multidrug-resistant tuberculosis. Clin Microbiol Infect. 2014 May; 20(5):441-6.
    View in: PubMed
  5. Palazuelos D, Ellis K, Im DD, Peckarsky M, Schwarz D, Farmer DB, Dhillon R, Johnson A, Orihuela C, Hackett J, Bazile J, Berman L, Ballard M, Panjabi R, Ternier R, Slavin S, Lee S, Selinsky S, Mitnick CD. 5-SPICE: the application of an original framework for community health worker program design, quality improvement and research agenda setting. Glob Health Action. 2013; 6:19658.
    View in: PubMed
  6. Mitnick CD, Keravec J, Cohen T. Planning for the invisible: projecting resources needed to identify and treat all patients with MDR-TB. Int J Tuberc Lung Dis. 2013 Apr; 17(4):427-8.
    View in: PubMed
  7. Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, Bayona JN, Bonilla CA, Chalco K, Fraser HS, Furin JJ, Guerra D, Hurtado RM, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Seung KJ, Shin SS, Sloutsky A, Tolman AW, Becerra MC. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLoS One. 2013; 8(3):e58664.
    View in: PubMed
  8. Lu C, Liu Q, Sarma A, Fitzpatrick C, Falzon D, Mitnick CD. A systematic review of reported cost for smear and culture tests during multidrug-resistant tuberculosis treatment. PLoS One. 2013; 8(2):e56074.
    View in: PubMed
  9. Becerra MC, Franke MF, Appleton SC, Joseph JK, Bayona J, Atwood SS, Mitnick CD. Tuberculosis in children exposed at home to multidrug-resistant tuberculosis. Pediatr Infect Dis J. 2013 Feb; 32(2):115-9.
    View in: PubMed
  10. Franke MF, Appleton SC, Mitnick CD, Furin JJ, Bayona J, Chalco K, Shin S, Murray M, Becerra MC. Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence. Clin Infect Dis. 2013 Mar; 56(6):770-6.
    View in: PubMed
  11. Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2012 Oct; 16(10):1335-43.
    View in: PubMed
  12. Dooley KE, Mitnick C, Degroote MA, Obuku E, Hamilton CD, Makhene M, Shah S, Brust JC, Durakovic N, Nuermberger E. Reply to Seddon, Schaaf, and Hesseling. Clin Infect Dis. 2013 Jan; 56(1):168-9.
    View in: PubMed
  13. Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, Dung NH, Enarson D, Falzon D, Flanagan K, Flood J, Garcia-Garcia ML, Gandhi N, Granich RM, Hollm-Delgado MG, Holtz TH, Iseman MD, Jarlsberg LG, Keshavjee S, Kim HR, Koh WJ, Lancaster J, Lange C, de Lange WC, Leimane V, Leung CC, Li J, Menzies D, Migliori GB, Mishustin SP, Mitnick CD, Narita M, O'Riordan P, Pai M, Palmero D, Park SK, Pasvol G, Peña J, Pérez-Guzmán C, Quelapio MI, Ponce-de-Leon A, Riekstina V, Robert J, Royce S, Schaaf HS, Seung KJ, Shah L, Shim TS, Shin SS, Shiraishi Y, Sifuentes-Osornio J, Sotgiu G, Strand MJ, Tabarsi P, Tupasi TE, van Altena R, Van der Walt M, Van der Werf TS, Vargas MH, Viiklepp P, Westenhouse J, Yew WW, Yim JJ. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012; 9(8):e1001300.
    View in: PubMed
  14. Dooley KE, Obuku EA, Durakovic N, Belitsky V, Mitnick C, Nuermberger EL. World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential? J Infect Dis. 2013 May 1; 207(9):1352-8.
    View in: PubMed
  15. Kurbatova EV, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Viiklepp P, Zignol M, Cegielski JP. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis (Edinb). 2012 Sep; 92(5):397-403.
    View in: PubMed
  16. Loddenkemper R, Sotgiu G, Mitnick CD. Cost of tuberculosis in the era of multidrug resistance: will it become unaffordable? Eur Respir J. 2012 Jul; 40(1):9-11.
    View in: PubMed
  17. Daitch J, Frey ME, Silver D, Mitnick C, Daitch D, Pergolizzi J. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine. Pain Physician. 2012 Jul; 15(3 Suppl):ES59-66.
    View in: PubMed
  18. Dooley KE, Mitnick CD, Ann DeGroote M, Obuku E, Belitsky V, Hamilton CD, Makhene M, Shah S, Brust JC, Durakovic N, Nuermberger E. Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis. Clin Infect Dis. 2012 Aug; 55(4):572-81.
    View in: PubMed
  19. Alexy ER, Podewils LJ, Mitnick CD, Becerra MC, Laserson KF, Bonilla C. Concordance of programmatic and laboratory-based multidrug-resistant tuberculosis treatment outcomes in Peru. Int J Tuberc Lung Dis. 2012; 16(3):364-9.
    View in: PubMed
  20. Furin J, Gegia M, Mitnick C, Rich M, Shin S, Becerra M, Drobac P, Farmer P, Hurtado R, Joseph JK, Keshavjee S, Kalandadze I. Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience. Bull World Health Organ. 2012 Jan 1; 90(1):63-6.
    View in: PubMed
  21. Kurbatova EV, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP. Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment. Int J Tuberc Lung Dis. 2011 Nov; 15(11):1553-5, i.
    View in: PubMed
  22. Gammino VM, Taylor AB, Rich ML, Bayona J, Becerra MC, Bonilla C, Gelmanova I, Hollo V, Jaramillo E, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riektsina V, Tupasi TE, Wells CD, Zignol M, Cegielski PJ. Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects. Int J Tuberc Lung Dis. 2011 Oct; 15(10):1315-22.
    View in: PubMed
  23. Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, Fitzpatrick C, Gebhard A, Getahun H, Henkens M, Holtz TH, Keravec J, Keshavjee S, Khan AJ, Kulier R, Leimane V, Lienhardt C, Lu C, Mariandyshev A, Migliori GB, Mirzayev F, Mitnick CD, Nunn P, Nwagboniwe G, Oxlade O, Palmero D, Pavlinac P, Quelapio MI, Raviglione MC, Rich ML, Royce S, Rüsch-Gerdes S, Salakaia A, Sarin R, Sculier D, Varaine F, Vitoria M, Walson JL, Wares F, Weyer K, White RA, Zignol M. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011 Sep; 38(3):516-28.
    View in: PubMed
  24. Izu A, Cohen T, Mitnick C, Murray M, De Gruttola V. Bayesian methods for fitting mixture models that characterize branching tree processes: An application to development of resistant TB strains. Stat Med. 2011 Sep 30; 30(22):2708-20.
    View in: PubMed
  25. Cox H, Ford N, Keshavjee S, McDermid C, von Schoen-Angerer T, Mitnick C, Goemaere E. Rational use of moxifloxacin for tuberculosis treatment. Lancet Infect Dis. 2011 Apr; 11(4):259-60.
    View in: PubMed
  26. Becerra MC, Appleton SC, Franke MF, Chalco K, Arteaga F, Bayona J, Murray M, Atwood SS, Mitnick CD. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Lancet. 2011 Jan 8; 377(9760):147-52.
    View in: PubMed
  27. Mitnick C, Horsburgh CR. Encouraging news for multidrug-resistant tuberculosis treatment. Am J Respir Crit Care Med. 2010 Dec 1; 182(11):1337-8.
    View in: PubMed
  28. Stryjewski TP, Benadretti DB, Zhao SD, Rowe S, Mitnick CD. Preliminary clinical outcomes from the Peruvian National Cataract Elimination Plan. Rev Panam Salud Publica. 2010 Oct; 28(4):282-8.
    View in: PubMed
  29. Becerra MC, Appleton SC, Franke MF, Chalco K, Bayona J, Murray MB, Mitnick CD. Recurrence after treatment for pulmonary multidrug-resistant tuberculosis. Clin Infect Dis. 2010 Sep 15; 51(6):709-11.
    View in: PubMed
  30. Jacobson KR, Tierney DB, Jeon CY, Mitnick CD, Murray MB. Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis. 2010 Jul 1; 51(1):6-14.
    View in: PubMed
  31. Mitnick CD, McGee B, Peloquin CA. Tuberculosis pharmacotherapy: strategies to optimize patient care. Expert Opin Pharmacother. 2009 Feb; 10(3):381-401.
    View in: PubMed
  32. Mitnick CD, Appleton SC, Shin SS. Epidemiology and treatment of multidrug resistant tuberculosis. Semin Respir Crit Care Med. 2008 Oct; 29(5):499-524.
    View in: PubMed
  33. Bonilla CA, Crossa A, Jave HO, Mitnick CD, Jamanca RB, Herrera C, Asencios L, Mendoza A, Bayona J, Zignol M, Jaramillo E. Management of extensively drug-resistant tuberculosis in Peru: cure is possible. PLoS One. 2008; 3(8):e2957.
    View in: PubMed
  34. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008 Aug 7; 359(6):563-74.
    View in: PubMed
  35. Cobelens FG, Heldal E, Kimerling ME, Mitnick CD, Podewils LJ, Ramachandran R, Rieder HL, Weyer K, Zignol M. Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda. PLoS Med. 2008 Jul 8; 5(7):e150.
    View in: PubMed
  36. Franke MF, Appleton SC, Bayona J, Arteaga F, Palacios E, Llaro K, Shin SS, Becerra MC, Murray MB, Mitnick CD. Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment. Clin Infect Dis. 2008 Jun 15; 46(12):1844-51.
    View in: PubMed
  37. Mitnick CD, Castro KG, Harrington M, Sacks LV, Burman W. Randomized trials to optimize treatment of multidrug-resistant tuberculosis. PLoS Med. 2007 Nov 6; 4(11):e292.
    View in: PubMed
  38. Nardell EA, Mitnick CD. Are second-line drugs necessary to control multidrug-resistant tuberculosis? J Infect Dis. 2006 Nov 1; 194(9):1194-6.
    View in: PubMed
  39. Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis. 2006 Sep; 12(9):1389-97.
    View in: PubMed
  40. Drobac PC, Mukherjee JS, Joseph JK, Mitnick C, Furin JJ, del Castillo H, Shin SS, Becerra MC. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics. 2006 Jun; 117(6):2022-9.
    View in: PubMed
  41. Shin SS, Furin JJ, Alcántara F, Bayona J, Sánchez E, Mitnick CD. Long-term follow-up for multidrug-resistant tuberculosis. Emerg Infect Dis. 2006 Apr; 12(4):687-8.
    View in: PubMed
  42. Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB. Int J Tuberc Lung Dis. 2006 Mar; 10(3):290-6.
    View in: PubMed
  43. Heldal E, Gammino V, Hollo V, Laserson K, Mitnick C, Rich M, Trebucq A. Category IV recording and reporting system. Stop TB Department, World Health Organization. Guidelines for the Programmatic Management of Drug-Resistant Tuerculosis. 2006; 114-123.
  44. Heldal E, Gammino V, Hollo V, Laserson K, Mitnick C, Rich M, Trebucq A. Definitions: case registration, bacteriology and treatment outcomes. Stop TB Department, World Health Organization. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. 2006; 18-23.
  45. Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, Zarovska E, Rich ML, Fraser HS, Alarcón E, Cegielski JP, Grzemska M, Gupta R, Espinal M. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2005 Jun; 9(6):640-5.
    View in: PubMed
  46. Mitnick, CD. Operational Research in Tuberculosis. 2005.
  47. Park SK, Lee WC, Lee DH, Mitnick CD, Han L, Seung KJ. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. Int J Tuberc Lung Dis. 2004 Mar; 8(3):361-8.
    View in: PubMed
  48. Choi SS, Jazayeri DG, Mitnick CD, Chalco K, Bayona J, Fraser HS. Implementation and initial evaluation of a Web-based nurse order entry system for multidrug-resistant tuberculosis patients in Peru. Stud Health Technol Inform. 2004; 107(Pt 1):202-6.
    View in: PubMed
  49. Chavez Pachas AM, Blank R, Smith Fawzi MC, Bayona J, Becerra MC, Mitnick CD. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru. Int J Tuberc Lung Dis. 2004 Jan; 8(1):52-8.
    View in: PubMed
  50. Shin SS, Hyson AM, Castañeda C, Sánchez E, Alcántara F, Mitnick CD, Fawzi MC, Bayona J, Farmer PE, Kim JY, Furin JJ. Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2003 Apr; 7(4):347-53.
    View in: PubMed
  51. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcántara F, Sánchez E, Sarria M, Becerra M, Fawzi MC, Kapiga S, Neuberg D, Maguire JH, Kim JY, Farmer P. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med. 2003 Jan 9; 348(2):119-28.
    View in: PubMed
  52. Partners In Health. The PIH Guide to the Medical Management of Multidrug-Resistant Tuberculosis. 2003.
  53. Partners In Health/Program in Infectious Disease and Social Change. A Dots-Plus Handbook: Guide to the Community-Based Treatment of MDR-TB. 2002.
  54. Fraser HS, Jazayeri D, Mitnick CD, Mukherjee JS, Bayona J. Informatics tools to monitor progress and outcomes of patients with drug resistant tuberculosis in Peru. Proc AMIA Symp. 2002; 270-4.
    View in: PubMed
  55. Kim JY, Mitnick CD, Bayona J, Blank R, Nardell E, Mukherjee JS, Rich ML, Farmer PE, Becerra MC, Murray M. Examing assumptions about multidrug-resistant TB control. Bulletin of the World Health Organization. 2002; 80(6):498-9.
  56. Program in Infectious Disease and Social Change in consultation with Stop TB Department, World Health Organization. Statement on the Role of the Corporate Sector in Global Tuberculosis Control. 2002.
  57. Fraser HS, Jazayeri D, Mitnick CD, Mukherjee JS, Bayona J. Informatics tools to monitor progress and outcomes of patients with drug resistant tuberculosis in Peru. Proceedings of AMIA Symposium. 2002; 270-4.
  58. Furin JJ, Mitnick CD, Shin SS, Bayona J, Becerra MC, Singler JM, Alcantara F, Castañieda C, Sanchez E, Acha J, Farmer PE, Kim JY. Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2001 Jul; 5(7):648-55.
    View in: PubMed
  59. Mitnick, CD. Outcomes of Directly Observed, Individualized Community-Based Therapy for Multidrug-Resistant Tuberculosis in a Shantytown in Northern Lima, Peru. 2001.
  60. Widmer S, Mitnick C, editors. Review of Tuberculosis Control Programs in Eastern and Central Europe and the Former Soviet Union. 2001.
  61. Mitnick, CD. Poverty, Culture and Infectious Diseases. 2000.
  62. Farmer PE, Kim JY, Mitnick CD, Timperi R. Responding to outbreaks of MDR-TB: introducing DOTS-plus. Reichman LB, Hershfield ES, eds. Tuberculosis: A Comprehensive International Approach. 2000; 447-69.
  63. Mitnick, CD. Health of Prisoners. 1999.
  64. Farmer P, Furin J, Bayona J, Becerra M, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. Management of MDR-TB in resource-poor countries. Int J Tuberc Lung Dis. 1999 Aug; 3(8):643-5.
    View in: PubMed
  65. Mitnick CD, Farmer PE. . Promise and peril: TB and multidrug-resistant tuberculosis in Azerbaijan. Farmer PE, Becerra M, Kim JY, eds. The Global Impact of Drug-Resistant Tuberculosis. 1999; 87-105..
  66. Farmer PE, Bayona J, Becerra M, Furin J, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. DOTS plus strategy in resource-poor countries. International Journal of Tuberculosis and Lung Disease. 1999; 3(9):844.
  67. Farmer P, Bayona J, Becerra M, Furin J, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. The dilemma of MDR-TB in the global era. Int J Tuberc Lung Dis. 1998 Nov; 2(11):869-76.
    View in: PubMed
  68. Mitnick C, Furin J, Henry C, Ross J. Tuberculosis among the foreign born in Massachusetts, 1982-1994: a reflection of social and economic disadvantage. Int J Tuberc Lung Dis. 1998 Sep; 2(9 Suppl 1):S32-40.
    View in: PubMed
  69. Partners In Health. Normes et procedures du traitement de la tuberculose. Clinique Bon Sauveur, Zanmi Lasante. 1998.
  70. Fawzi MC, Jean-Baptiste M, Rosenthal B, Mitnick C. Health impact of human rights violations in Haitian refugees. Lancet. 1997 Aug 2; 350(9074):371-2.
    View in: PubMed
  71. Farmer P, Bayona J, Becerra M, Daily J, Furin J, Garcia D, Henry C, Kim J, Mitnick C, Nardell E, Raymonville M, Shin S, Small P. Poverty, inequality and drug resistance: meeting community needs. Proceedings of the International Union Against Tuberculosis and Lung Disease. 1997; 88-102.
  72. Mitnick, CD. Consumption of the Poor: Tuberculosis in the 20th Century. 1996.
  73. Holmes A, Barnett E, Mitnick C, Phillips S, Gas M, Wais M, Wilson M. . The development of an appropriate screening and treatment strategy for schistosomiasis in the Somalian refugee population followed at Boston City Hospital's International Clinic. Proceedings of the Infectious Disease Society of America, 33rd Meeting. 1995.
  74. Mitnick, CD. Evaluation and Monitoring of Public Health Interventions in Developing Countries. 1995.
  75. Mitnick, C. Epidemiology of Infectious Diseases of Importance in Developing Countries. 1994.
  76. Wilson A, Michaels B, Mitnick C, editors. Malaria and Development in Sub-Saharan Africa. 1991.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Mitnick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_